Illumina GenoLogics Purchase: Securing a Pathway for Instrument Usage

Illumina GenoLogics Purchase: Securing a Pathway for Instrument Usage

Illumina’s deal to buy long-time partner GenoLogics and its Clarity platform is evidence of a trend: that makers of analytical equipment are turning to IT systems to boost user loyalty and consumable growth.   These types of deals are becoming more common.  Whether through purchases or partnerships, companies are gaining IT capabilities.  Kalorama estimates the market for laboratory information systems for clinical laboratories to be $926 million in 2015, but their value-added to other equipment markets can be much greater.   Our most recent reporting on IT companies serving laboratories is Laboratory Information Systems

We reported in 2013 that over 60 significant companies participate in laboratory information systems market, and the number has only increases since then.   We speculate that some of the companies involved in LIMS could now be takeover targets, as the world’s largest diagnostics company, Roche Diagnostics, purchased Bina Informatics last December.  
Expect more of these type of deals, because the information systems will drive usage of the system and suppliers will want to secure a LIMS solution.  That was Illumina’s logic in this deal, and they are the lead manufacturer of next-generation systems. 

Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories.  Advances in DNA and RNA sequencing technologies and the commercialization of next-generation sequencing instrumentation in recent years has made it possible to automate several steps of laboratory processes, leading to an increased throughput. As a consequence, there has been an exponential growth of data generated, along with the evolution of more efficient and complicated procedures and processes in the lab.

GenoLogics offers on-premise and cloud LIMS systems that work with Illumina sequencers.  The relationship between GenoLogics and Illumina has been one of increased cooperation.   Illumina made GenoLogics the preferred LIMS provider for its next-generation sequencing (NGS) systems eight years ago, then entered into a LIMS for NGS co-marketing deal.  GenoLogics started selling software preconfigured for its partner’s systems, and Illumina raised capital for GenoLogics.   Illumina deepened its ties to GenoLogics last month by including its LIMS in a support package for its HiSeq X systems before actually purchasing the company.    
Kalorama Information’s report, Laboratory Information Systems (LIS / LIMS): Software, Hardware and Service Markets for Clinical Labs and Drug Discovery Labs contains market forecasts for the LIMS industry and detailed profiles of LIS competitors.  Available ranking of LIS systems is also provided.  The report is available at  http://www.kaloramainformation.com/Laboratory-Information-Systems-7796512/